Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
RXRX
UFPT
Add up to 3 more stocks
RXRX
Recursion Pharmaceuticals, Inc.
-3.14%
$4.63-0.15Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.43B
52W Range
$2.77 - $7.18
UFPT
UFP Technologies, Inc.
-1.45%
$302.87-4.46Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.34B
52W Range
$173.86 - $338.71
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 32.67 |
| Forward P/E | N/A | 31.09 |
| PEG Ratio | N/A | 0.87 |
| P/B Ratio | 2.65 | 5.07 |
| P/S Ratio | 44.29 | 3.71 |
| P/FCF Ratio | N/A | 38.15 |
| EV/EBITDA | N/A | 20.54 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -62.0% | 28.5% |
| Operating Margin | -867.9% | 15.3% |
| Net Margin | -945.9% | 11.4% |
| ROE | -56.7% | 15.6% |
| ROA | -42.8% | 10.6% |
| ROIC | -49.8% | 12.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.03 | 3.00 |
| Quick Ratio | 5.03 | 1.72 |
| Debt/Equity | 0.07 | 0.29 |
| Interest Coverage | -358.08 | 9.42 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.